Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Dr. Arevitalize vs Remi Meds

Dr. Arevitalize
Graded #225

Higher grade

vs+16.800000000000004
Remi Meds
Graded #493

Lower grade

The verdict

Dr. Arevitalize takes it — 65.2/100 to 48.4/100.

Dr. Arevitalize grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Dr. Arevitalize (Dr.Arevitalize Health, Inc.) is a LegitScript-certified telehealth platform offering compounded GLP-1 weight-loss medication in both injectable and oral-capsule forms — semaglutide fr

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueDr. Arevitalize +5
39
34
Dose & formulationDr. Arevitalize +21
75
54
Clinical oversightDr. Arevitalize +17
71
54
Labs & monitoringDr. Arevitalize +38
88
50
FulfillmentDr. Arevitalize +19
72
53
Contract termsEven
55
55
Dr. Arevitalize · left barRemi Meds · right bar

The numbers

MetricDr. ArevitalizeRemi Meds
WeighScore65.2/10048.4/100
GradeCC
Scorecard rank#225#493
Semaglutide$319/mo (compounded)$249/mo (0.25 mg dose, compounded)
Tirzepatide$359/mo (compounded)$349/mo (2.25 mg dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Dr. Arevitalize

Graded #225 · C

Strengths

  • Offers both injectable and oral-capsule compounded GLP-1 — a needle-free option many providers do not carry
  • Semaglutide from $269/mo and tirzepatide from $349/mo, in 1-, 3-, 6-, and 12-month bundles
  • LegitScript-certified; clinician-guided with lab/bloodwork analysis and personalized plans
  • Intro pricing on injectable semaglutide ($269, was $319) and oral semaglutide ($299, was $349)

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products
  • Compounding pharmacy partner and prescribing clinician are not named on the site
  • State availability is not published on the site
Remi Meds

Graded #493 · C

Strengths

  • Names its compounding pharmacy (Strive Pharmacy, Gilbert AZ) — stronger transparency than peers
  • LegitScript verification badge on the homepage
  • Publishes 503A FDCA compliance language on the tirzepatide page
  • Per-dose-tier pricing fully shown — no 'as low as' floor-only obfuscation
  • Operating corporate entity disclosed (T-C Health Co)

Where it loses points

  • No named medical director, founder, or physician on any public page
  • States served not listed — 'nationwide' claim with no per-state detail
  • Clinical care runs through Beluga Health, a network a 2026 StatNews analysis tied to many FDA-warned GLP-1 companies (Remi Meds itself not FDA-warned)
  • Year founded and corporate history are opaque
  • Two phone numbers and a secondary 'Rekindle RX' email hint at shared infrastructure

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard